Granules India Ltd. Financials

NSE BSE

15:57 Sep 12

Granules India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

534.35

+8.25 (+1.57%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

534.35

+8.25 (+1.57%)
15:57 Sep 12

Quality

59/100
High Financial Strength

Valuation

41/100
Mid Valuation

Technical

51/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	3764.92	4511.92	4506.37	4481.61	4511.86
Operating Expenses +	3042.69	3598.1	3650.39	3536.37	3579.16
Raw Material	2036.42	2352.65	2208.22	1724.94	1670.44
Increase Decrease in Cost	-152.78	-45.37	-186.97	0.76	-4.12
Other Manufacturing Expense	22.01	19.98	0	0	0
Employee Cost	401.38	472.23	597.86	659.8	698.94
Miscellaneous Expenses	735.66	798.61	1031.28	1150.87	1213.9
Operating Profit	722.23	913.82	855.98	945.24	932.7
Other Income	17.61	13.78	4.4	12.92	27.2
Depreciation	158.63	184.49	207.33	225.5	241.48
Interest	23.21	55.93	105.82	103.24	100
Profit before tax and exceptio..	558	687.17	547.23	629.42	618.42
Exceptional Items	0	0	0	30.75	4.84
PBT	558	687.17	547.23	660.17	613.58
Provision for Taxation	145.24	170.58	141.92	158.65	143.75
Net Profit	412.76	516.6	405.31	501.52	479.5
NET Profit after MI	412.76	516.6	405.31	501.52	479.5
EPS	16.6	21	16.73	20.68	19.77
Operating Profit Margin (%)	19.18	20.25	18.99	21.09	20.67
Net Profit Margin (%)	10.96	11.45	8.99	11.19	10.63

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	38.80	38.80	38.80	38.90	38.90
FII	13.20	15.10	15.90	19.50	20.40
MF	12.20	11.60	10.40	7.90	9.20
Others	11.40	10.90	9.10	6.90	4.90

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: